887 related articles for article (PubMed ID: 18946205)
21. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
[TBL] [Abstract][Full Text] [Related]
22. Plasma thiols and their determinants in phenylketonuria.
Colomé C; Artuch R; Sierra C; Brandi N; Lambruschini N; Campistol J; Vilaseca MA
Eur J Clin Nutr; 2003 Aug; 57(8):964-8. PubMed ID: 12879091
[TBL] [Abstract][Full Text] [Related]
23. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.
Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR
Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577
[TBL] [Abstract][Full Text] [Related]
24. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
[TBL] [Abstract][Full Text] [Related]
25. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
[TBL] [Abstract][Full Text] [Related]
26. "Hypotyrosinemia" in phenylketonuria.
Hanley WB; Lee AW; Hanley AJ; Lehotay DC; Austin VJ; Schoonheyt WE; Platt BA; Clarke JT
Mol Genet Metab; 2000 Apr; 69(4):286-94. PubMed ID: 10870846
[TBL] [Abstract][Full Text] [Related]
27. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
28. Executive functioning in children and adolescents with phenylketonuria.
VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
[TBL] [Abstract][Full Text] [Related]
29. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
[TBL] [Abstract][Full Text] [Related]
30. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria.
Beblo S; Reinhardt H; Demmelmair H; Muntau AC; Koletzko B
J Pediatr; 2007 May; 150(5):479-84. PubMed ID: 17452220
[TBL] [Abstract][Full Text] [Related]
31. Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU).
Koletzko B; Beblo S; Demmelmair H; Hanebutt FL
J Pediatr Gastroenterol Nutr; 2009 Mar; 48 Suppl 1():S2-7. PubMed ID: 19214054
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy and safety of a phenylalanine-free amino acid-based enteral formula (AA-PKU2) in 1-8 year-old children with phenylketonuria: a prospective, open, self-controlled and multi-center study in China].
Zhou XL; Zhao ZY; Jiang JH; Zou H; Gu XF; Gu Q; Shen M; Lu J
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):11-5. PubMed ID: 24461170
[TBL] [Abstract][Full Text] [Related]
33. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets.
Clarke JT; Gates RD; Hogan SE; Barrett M; MacDonald GW
Am J Ment Retard; 1987 Nov; 92(3):255-62. PubMed ID: 3426836
[TBL] [Abstract][Full Text] [Related]
35. [Use of a new amino acid mixture in the diet therapy of patients with classical phenylketonuria].
Riva E; Paccanelli S; Longhi R; Giovannini M
Pediatr Med Chir; 1983; 5(6):521-30. PubMed ID: 6681058
[TBL] [Abstract][Full Text] [Related]
36. Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria?
Macdonald A; Davies P; Daly A; Hopkins V; Hall SK; Asplin D; Hendriksz C; Chakrapani A
J Hum Nutr Diet; 2008 Aug; 21(4):351-8. PubMed ID: 18721402
[TBL] [Abstract][Full Text] [Related]
37. Unrestricted consumption of fruits and vegetables in phenylketonuria: no major impact on metabolic control.
Rohde C; Mütze U; Weigel JF; Ceglarek U; Thiery J; Kiess W; Beblo S
Eur J Clin Nutr; 2012 May; 66(5):633-8. PubMed ID: 22318648
[TBL] [Abstract][Full Text] [Related]
38. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
Moats RA; Moseley KD; Koch R; Nelson M
Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
[TBL] [Abstract][Full Text] [Related]
39. Experience with adolescents with phenylketonuria returned to phenylalanine-restricted diets.
Hogan SE; Gates RD; MacDonald GW; Clarke JT
J Am Diet Assoc; 1986 Sep; 86(9):1203-7. PubMed ID: 3745744
[TBL] [Abstract][Full Text] [Related]
40. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
